Researchers at Durham University have achieved a major advancement in understanding how proteins bind metals inside cells, a process crucial to life. The study, published in Nature Communications, ...

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Bioxyne lifts revenue 77% QoQ; Radiopharm listed on the Nasdaq in the December quarter; Tryptomine hits key milestones; Quarterly season is nearing its end, triggering a rush from ...

VANCOUVER, BC / ACCESS Newswire / January 29, 2025 / AZARGA METALS CORP. ("Azarga Metals" or the "Corporation") (TSXV:AZR) announces that the British Columbia Securities Commission (the "BCSC"), as th ...

Having trouble finding a Sector - Health fund? Fidelity Advisor Biotechnology A (FBTAX) is a potential starting point. FBTAX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various ...

While Wall Street’s panic over the Chinese AI breakthrough has faded, there are signs of bubbles and FOMO that have not been ...

Shares of Leap Therapeutics slid after disappointing initial data from two mid-stage clinical trials of its oncology treatment, resulting in the discontinuation of one clinical program.

Stephens reiterated their equal weight rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research report report ...

2025 Half-Year Business and Financial Report (as of June 30, 2025) ...

As scientific discovery and technology advance, new opportunities arise and business priorities shift throughout the global ...

The upcoming Biotech Act will be part of the measures the Commission will target to turbo-charge investment and efficiency in ...

ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data update from ...